What is Evommune 's interest expense, nonoperating?

Evommune (EVMN) reported interest expense, nonoperating of $25.8K in Q1 2026.

How has Evommune 's interest expense, nonoperating changed year-over-year?

Evommune 's interest expense, nonoperating decreased by 72.9% year-over-year, from $95.09K to $25.8K.

What does interest expense, nonoperating mean?

Represents the cost incurred by the company for borrowed funds, excluding any interest expenses directly related to core operations. This metric highlights the financial burden of the company's debt structure and its impact on net earnings.

Evommune EVMN Interest Expense, Nonoperating

Interest Expense, Nonoperating at other companies

Cal-Maine FoodsCALM

$153K+11.5%

Evommune EVMN

$25.8K-72.9%

Ondas, Inc. ONDS

$338K-91.3%

Quantum Computing Inc.QUBT

$171K+195%

Capricor TherapeuticsCAPR

$761.43K—

HTF

Heartflow, Inc. Common StockHTFL

$3K-99.9%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's interest expense, nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's interest expense, nonoperating?: Evommune (EVMN) reported interest expense, nonoperating of $25.8K in Q1 2026.
How has Evommune 's interest expense, nonoperating changed year-over-year?: Evommune 's interest expense, nonoperating decreased by 72.9% year-over-year, from $95.09K to $25.8K.
What does interest expense, nonoperating mean?: Represents the cost incurred by the company for borrowed funds, excluding any interest expenses directly related to core operations. This metric highlights the financial burden of the company's debt structure and its impact on net earnings.